BSE filing, NSE: GRMOVER. Summary written from the filing by ALFA Finder's alert engine.
GRM Overseas Ltd: key numbers
- Share price
- ₹90.61
- Market cap
- ₹1,878 Cr
- Revenue (annual)
- ₹1,769 Cr
- Net profit (annual)
- ₹74.34 Cr
- P/E (TTM)
- 24.5×Sector 29.0×
- Promoter holding
- 63.06%+0.00% QoQ
- FII holding
- 6.35%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from GRM Overseas Ltd
All →GRM Overseas Board Meeting Date
GRM Overseas Limited will hold a board meeting on 14 November 2026 to consider unaudited standalone and consolidated half-yearly results for September 2026. Trading window closes 1 October to 16 November 2026.
GRM Overseas Other Announcement
GRM Overseas Limited filed its quarterly compliance certificate under Regulation 74(5) of SEBI Regulations, confirming the timely processing of dematerialization requests by its registrar.
GRM Overseas Annual General Meeting
GRM Overseas Limited held its 32nd Annual General Meeting on September 29, 2026, to adopt financial statements, re-appoint a director, and approve material related party transactions.
GRM Overseas Annual General Meeting
GRM Overseas Limited issued notice for its 32nd Annual General Meeting scheduled on September 29, 2026. The agenda includes financial statement adoption and related party transaction approvals.
GRM Overseas Annual Report
GRM Overseas submitted its Annual Report for FY 2025-26 and the notice for its 32nd Annual General Meeting scheduled for September 29, 2026.
GRM Overseas Board Meeting Outcome
GRM Overseas announced the approval of its Annual Report and notice for the upcoming 32nd Annual General Meeting scheduled for September 29, 2026.
Other product launch announcements
All →Jeena Sikho Lifecare Product Launch
Jeena Sikho Lifecare launched ten new Ayurvedic healthcare products in the domestic market on November 11, 2026. The filing gives product-wise details under SEBI product-launch disclosure rules.
HCL Technologies Product Launch
HCLTech launched a pre-configured semiconductor PLM solution built on PTC Windchill, developed in collaboration with PTC. The release states no contract value or deal size, and the launch is a new product offering.
Morepen Laboratories Product Launch
Morepen launched Desloratadine Tablets USP 5 mg, its first US prescription generic, through subsidiary Morepen Bio Inc. It also filed a Sitagliptin ANDA with the US FDA.
AstraZeneca Pharma India Product Launch
AstraZeneca Pharma India will launch Datverzo, Datopotamab Deruxtecan, in India in November 2026. The drug holds DCGI import and market permission for HR-positive, HER2-negative breast cancer.
Raama Finance Product Launch
Raama Finance launched 'Rupya Lelo', a digital lending platform offering instant personal loans, on October 6, 2026. The product is available only in India, and no loan amount or financial figure is disclosed.
Puravankara Product Launch
Puravankara will launch the residential project Purva Cityspire Phases 1, 2 and 3 in Ernakulam on 15 November 2026. The project is RERA-registered and is being developed by two wholly owned subsidiaries.